Sujatha Chilakala
Bibliographic
-
Chilakala S, Feng Y, Li L, Mahfouz R, Quteba E, Saunthararajah Y, Xu Y. Tracking Decitabine Incorporation into Malignant Myeloid Cell DNA in vitro and in vivo by LC-MS/MS with Enzymatic Digestion. Sci Rep. 2019 Mar 14; 9(1):4558. PMID: 30872721.
-
Chilakala S, Cheng I, Lee I, Xu Y. Analysis of oxygen-18 labeled phosphate to study positional isotope experiments using LC-QTOF-MS. Anal Biochem. 2019 02 01; 566:62-66. PMID: 30419188.
-
Chilakala S, Li L, Feng Y, Xu Y. Microwave-assisted enzymatic hydrolysis of DNA for mass spectrometric analysis: A new strategy for accelerated hydrolysis. Anal Biochem. 2018 04 01; 546:28-34. PMID: 29408176.
-
Fishovitz J, Sha Z, Chilakala S, Cheng I, Xu Y, Lee I. Utilization of Mechanistic Enzymology to Evaluate the Significance of ADP Binding to Human Lon Protease. Front Mol Biosci. 2017; 4:47. PMID: 28744459.
-
Vatolin S, Phillips JG, Jha BK, Govindgari S, Hu J, Grabowski D, Parker Y, Lindner DJ, Zhong F, Distelhorst CW, Smith MR, Cotta C, Xu Y, Chilakala S, Kuang RR, Tall S, Reu FJ. Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma. Cancer Res. 2016 06 01; 76(11):3340-50. PMID: 27197150.
-
Papp-Wallace KM, Winkler ML, Gatta JA, Taracila MA, Chilakala S, Xu Y, Johnson JK, Bonomo RA. Reclaiming the efficacy of ß-lactam-ß-lactamase inhibitor combinations: avibactam restores the susceptibility of CMY-2-producing Escherichia coli to ceftazidime. Antimicrob Agents Chemother. 2014 Aug; 58(8):4290-7. PMID: 24820081.
|
Concepts Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
|